Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2023 13:30 ET | Source: PMI

Scleroderma Therapeutics Market is estimated to be US$ 4.3 Billion by 2032; Growing Incidence and Screening Rates of Scleroderma to Fuel-By PMI

Covina, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Scleroderma, also known as systemic sclerosis, is a rare and chronic autoimmune disease that primarily affects the connective tissues in the body. There...